CoChat

Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia

Open access
Yolland, Caitlin OB, Hanratty, Donal, Neill, Erica, Rossell, Susan L, Berk, Michael, Dean, Olivia M, Castle, David J, Tan, Eric J, Phillipou, Andrea, Harris, Anthony WF, Barreiros, Ana Rita, Hansen, Abigail, Siskind, Dan · 2020 · Australian & New Zealand Journal of Psychiatry
Cited by 107

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Objective: There is accumulating evidence that adjunctive treatment with N-acetylcysteine may be effective for schizophrenia. This study aimed to conduct a comprehensive meta-analysis examining the efficacy of randomised control trials investigating N-acetylcysteine as an adjunct treatment for schizophrenia and the first to investigate cognition as an outcome. Methods: We systematically reviewed Medline, EmCare, PsycINFO, Embase, CINAHL Complete, China Knowledge Resource Integrated Database and the Cochrane Clinical Trials online registry for randomised control trials of N-acetylcysteine for schizophrenia. We undertook pairwise meta-analyses of N-acetylcysteine vs placebo for psychosis symptoms and cognition. Results: Seven studies, including n = 220 receiving N-acetylcysteine and n = 220 receiving placebo, met inclusion criteria for the pairwise meta-analyses. Positive and Negative Syndrome Scale negative and total scores were significantly improved in the N-acetylcysteine group after 24 weeks of treatment. The cognitive domain of working memory improved with N-acetylcysteine supplementation. Conclusion: Evidence supports the notion that N-acetylcysteine may be a useful adjunct to standard treatment for the improvement of schizophrenia symptoms, as well as the cognitive domain of working memory. Treatment effects were observed at the later time point (⩾24 weeks), suggesting that longer interventions are required for the success of N-acetylcysteine treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0004867419893439

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 107

Metadata

Authors
Yolland, C. O., Hanratty, D., Neill, E., Rossell, S. L., Berk, M., Dean, O. M., Castle, D. J., Tan, E. J., Phillipou, A., Harris, A. W., Barreiros, A. R., Hansen, A., & Siskind, D.
Venue
Australian & New Zealand Journal of Psychiatry
Published
2019-12-11
Volume
54
Issue
5
Pages
453-466
ISSN
  • 0004-8674 (ISSN-L)
  • 1440-1614
OpenAlex
W2996543290
Cited by
107
References
9
FWCI
2.18
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia. https://app.cochat.ai/papers/10.1177/0004867419893439
The paper
Yolland, C. O., Hanratty, D., Neill, E., Rossell, S. L., Berk, M., Dean, O. M., Castle, D. J., Tan, E. J., Phillipou, A., Harris, A. W., Barreiros, A. R., Hansen, A., & Siskind, D. (2020). Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867419893439

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.